Trials / Completed
CompletedNCT00067158
Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1
Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 585 (planned)
- Sponsor
- New York University · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | nicotine transdermal system |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2004-07-01
- Completion
- 2004-07-01
- First posted
- 2003-08-13
- Last updated
- 2017-01-12
Locations
13 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00067158. Inclusion in this directory is not an endorsement.